Respiratorius AB (FRA:HF00) Other Current Receivables: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HF00 Respiratorius AB FRA:HF00
34 GF Score
Price €0.19
View Full Analysis

What is Respiratorius AB Other Current Receivables?

Respiratorius AB FRA:HF00 -0.80% 34 Other Current Receivables is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:HF00 with a GF Score™ of 34/100.

Respiratorius AB's Other Current Receivables for the quarter that ended in Jun. 2026 was €0.00 Mil.

Respiratorius AB's quarterly Other Current Receivables declined from Dec. 2025 (€0.03 Mil) to Mar. 2026 (€0.00 Mil) but then stayed the same from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€0.00 Mil).

Respiratorius AB's annual Other Current Receivables increased from Dec. 2023 (€0.02 Mil) to Dec. 2024 (€0.03 Mil) but then declined from Dec. 2024 (€0.03 Mil) to Dec. 2025 (€0.03 Mil).

Respiratorius AB Other Current Receivables Related Terms

Respiratorius AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Other Current Receivables Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.06 0.02 0.03 0.03

Respiratorius AB Quarterly Data
Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.03 0.00 0.00
FRA:HF00
34GF Score
Respiratorius AB FRA:HF00
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.00 Mil mean?
Respiratorius AB (FRA:HF00) has a Other Current Receivables of €0.00 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Respiratorius AB and its competitors.
Is Respiratorius AB's Other Current Receivables too high?
Respiratorius AB's current Other Current Receivables is €0.00 Mil. Overall, Respiratorius AB has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's Other Current Receivables compare to VRTX and REGN?
Respiratorius AB's Other Current Receivables of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Respiratorius AB and its competitors. Respiratorius AB's current Other Current Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (FRA:HF00) has a current Other Current Receivables of €0.00 Mil. The current Other Current Receivables is €0.00 Mil. Respiratorius AB's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Respiratorius AB (FRA:HF00), the current Other Current Receivables is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Other Exchanges RESP:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
34GF Score

Get the complete analysis for FRA:HF00

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price